New data on an old weapon: is argon plasma coagulation adequate treatment for dysplastic Barrett’s esophagus?

Nicholas J. Shaheen

doi:10.1055/a-1230-5610

Endoscopy, Table of Contents

Endoscopy 2021; 53(02): 133-135
DOI: 10.1055/a-1230-5610

Editorial

New data on an old weapon: is argon plasma coagulation adequate treatment for dysplastic Barrett’s esophagus?

Referring to Wronska E et al. p. 123–132

Nicholas J. Shaheen

Center for Esophageal Diseases and Swallowing, and Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States

› Author Affiliations

Abstract

Full Text

References

References
1 Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett’s esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 1996; 44: 532-535
2 Overholt BF, Lightdale CJ, Wang K. et al. International, multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett’s esophagus (BE): results of a 24 month follow-up. Gastroenterology 2003; 124 (Suppl. 01) A20
3 Ganz RA, Overholt BF, Sharma VK. et al. Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 2008; 68: 35-40
4 Shaheen NJ, Sharma P, Overholt BF. et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
5 Wronska E, Polkowski M, Orlowska J. et al. Argon plasma coagulation for Barrett’s esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose. Endoscopy 2021; 123-132
6 Mashimo H. Subsquamous intestinal metaplasia after ablation of Barrett’s esophagus: frequency and importance. Curr Opin Gastroenterol 2013; 29: 454-459
7 Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology 2017; 153: 35-48
8 Sie C, Bright T, Schoeman M. et al. Argon plasma coagulation ablation versus endoscopic surveillance of Barrett’s esophagus: late outcomes from two randomized trials. Endoscopy 2013; 45: 859-865
9 Sharma P, Wani S, Weston AP. et al. A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 2006; 55: 1233-1239
10 Dulai GS, Jensen DM, Cortina G. et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett’s esophagus. Gastrointest Endosc 2005; 61: 232-240
11 Kahaleh M, Van Laethem JL, Nagy N. et al. Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 2002; 34: 950-955
12 Schulz H, Miehlke S, Antos D. et al. Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 2000; 51: 659-663
13 Peerally MF, Bhandari P, Ragunath K. et al. Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett’s esophagus: a randomized pilot study (BRIDE). Gastrointest Endosc 2019; 89: 680-689
14 Estifan E, Cavanagh Y, Grossman MA. Hybrid argon plasma coagulation for treatment of gastric intestinal metaplasia. Cureus 2020; 12: e7427
15 Manner H, May A, Kouti I. et al. Efficacy and safety of hybrid-APC for the ablation of Barrett’s esophagus. Surg Endosc 2016; 30: 1364-1370